CSL ORD
Weekly Wrap: Late pullback slams gold shares
ASX slips 0.7% as late pullback drags gold shares lower on Fed chair speculation; bullion drops ~5% amid rate-hike fears.
Want to buy some cut-price shares?
What would your reaction be if I told you I could get you some shares at a price that is significantly less than what they are actually worth? Well, most people would say here is a wheelbarrow, fill it up with shares but as always there is something of a catch. It is possible to […]
CSL reports 25% profit increase as immunoglobulins and plasma collections lead growth
Biotherapeutics giant CSL (ASX: CSL) has reported a net profit after tax of US$2.64 billion for the 12 months to 30 June, up 25% on a constant currency basis. Net profit after tax before amortisation was US$2.91b (up 15% on a constant currency basis), while revenue for the year was up 11% to US$14.8b. Total […]
CSL profits take US$250m hit from foreign currency movements
Foreign currency movements have dented the forecast profits of multi-national biotechnology company CSL (ASX: CSL) by up to US$250 million. The company this week reported higher-than-expected headwinds, up from an estimated US$175 million reported at the time of its half year results in February. Its constant currency profit guidance for the year remains unchanged, albeit […]
